Development and molecular characterization of hard-to-treat breast cancer pre-clinical models to enhance precision medicine

被引：0
|
作者：
Kuasne, Hellen
Fortier, Anne-Marie
Busque, Sandrine
Mathien, Simon
Savage, Paul
Ramirez, Constanza Martinez
Monast, Anie
Soleinova, Margarita
Omeroglu, Atilla
Asselah, Jamil
Bouganim, Nathaniel
Meterissian, Sarkis
Basik, Mark
Park, Morag
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-08-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-09
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting integrin-extracellular matrix interactions to treat breast cancer metastasis-8 pre-clinical perspective
    Pouliot, Normand
    Natoli, Anthony
    Carter, Rachel Z.
    Paquet-Fifeld, Sophie
    Denoyer, Delphine
    Selistre de Araujo, Heloisa Sobreiro
    Anderson, Robin L.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S41 - S41
  • [22] The Potential Effect of Lidocaine, Ropivacaine, Levobupivacaine and Morphine on Breast Cancer Pre-Clinical Models: A Systematic Review
    Matos, Ana Catarina
    Marques, Ines Alexandra
    Pires, Ana Salome
    Valentim, Ana
    Abrantes, Ana Margarida
    Botelho, Maria Filomena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [23] Characterisation of pre-clinical mesothelioma models for therapeutic and non-invasive molecular imaging strategies development
    Colin, D. J.
    Germain, S.
    Senoner, I.
    Triponez, F.
    Serre-Beinier, V.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 25 - 25
  • [24] Establishment of patient-derived xenografts (PDX) models for triple negative breast cancer (TNBC) as a pre-clinical platform for drug development
    Thatte, J.
    Meza, M.
    Ricono, J.
    Broudy, T.
    Mirsaidi, C.
    Nair, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 50 - 50
  • [25] Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
    Schuette, Moritz
    Risch, Thomas
    Abdavi-Azar, Nilofar
    Boehnke, Karsten
    Schumacher, Dirk
    Keil, Marlen
    Yildirimman, Reha
    Jandrasits, Christine
    Borodina, Tatiana
    Amstislavskiy, Vyacheslav
    Worth, Catherine L.
    Schweiger, Caroline
    Liebs, Sandra
    Lange, Martin
    Warnatz, Hans-Joerg
    Butcher, Lee M.
    Barrett, James E.
    Sultan, Marc
    Wierling, Christoph
    Golob-Schwarzl, Nicole
    Lax, Sigurd
    Uranitsch, Stefan
    Becker, Michael
    Welte, Yvonne
    Regan, Joseph Lewis
    Silvestrov, Maxine
    Kehler, Inge
    Fusi, Alberto
    Kessler, Thomas
    Herwig, Ralf
    Landegren, Ulf
    Wienke, Dirk
    Nilsson, Mats
    Velasco, Juan A.
    Garin-Chesa, Pilar
    Reinhard, Christoph
    Beck, Stephan
    Schaefer, Reinhold
    Regenbrecht, Christian R. A.
    Henderson, David
    Lange, Bodo
    Haybaeck, Johannes
    Keilholz, Ulrich
    Hoffmann, Jens
    Lehrach, Hans
    Yaspo, Marie-Laure
    NATURE COMMUNICATIONS, 2017, 8
  • [26] Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
    Moritz Schütte
    Thomas Risch
    Nilofar Abdavi-Azar
    Karsten Boehnke
    Dirk Schumacher
    Marlen Keil
    Reha Yildiriman
    Christine Jandrasits
    Tatiana Borodina
    Vyacheslav Amstislavskiy
    Catherine L. Worth
    Caroline Schweiger
    Sandra Liebs
    Martin Lange
    Hans- Jörg Warnatz
    Lee M. Butcher
    James E. Barrett
    Marc Sultan
    Christoph Wierling
    Nicole Golob-Schwarzl
    Sigurd Lax
    Stefan Uranitsch
    Michael Becker
    Yvonne Welte
    Joseph Lewis Regan
    Maxine Silvestrov
    Inge Kehler
    Alberto Fusi
    Thomas Kessler
    Ralf Herwig
    Ulf Landegren
    Dirk Wienke
    Mats Nilsson
    Juan A. Velasco
    Pilar Garin-Chesa
    Christoph Reinhard
    Stephan Beck
    Reinhold Schäfer
    Christian R. A. Regenbrecht
    David Henderson
    Bodo Lange
    Johannes Haybaeck
    Ulrich Keilholz
    Jens Hoffmann
    Hans Lehrach
    Marie-Laure Yaspo
    Nature Communications, 8
  • [27] Molecular tumor board (MTB): Development of clinical pathways for precision medicine. Experiences of center for breast cancer at national cancer center, Korea
    Park, I. H.
    Park, C.
    Jang, W.
    Yang, H.
    An, K.
    Kwon, Y.
    Lee, K. S.
    Sim, H.
    Kong, S. Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] The Anti-Tumor Effect of Motesanib in Pre-Clinical Models of Human Basal-Like Breast Cancer
    Price, J. E.
    Alvarez, R. H.
    Xu, C.
    Polverino, A.
    Radinsky, R.
    Coxon, A.
    Saffran, D.
    CANCER RESEARCH, 2009, 69 (24) : 784S - 784S
  • [29] A Review of Metabolic Targets of Anticancer Nutrients and Nutraceuticals in Pre-Clinical Models of Triple-Negative Breast Cancer
    Wiggs, Alleigh
    Molina, Sabrina
    Sumner, Susan J.
    Rushing, Blake R.
    NUTRIENTS, 2022, 14 (10)
  • [30] Development and characterization of novel pre-clinical models of SFPQ-TFE3-driven renal cell carcinoma
    Mendes, Adrianna Amaral De Aragao
    Liu, Hans
    Woo, Juhyung
    Asrani, Kaushal
    Rosenberg, Avi
    Argani, Pedram
    Lotan, Tamara
    CANCER RESEARCH, 2023, 83 (16)
12345